FITLIFE BRANDS, INC. (FTLF) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2025-09-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2025-09-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2025-09-30..
Borrowing debt
Overview →Financial period ending 2025-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2025-09-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2025-09-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2025-09-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 14.09M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 32.36M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 109.98M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | (m) | (m) | $14.09M | $32.36M | (m) | (m) | $109.98M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $6.32M | (m) | (m) | $62.85M | (m) |
| 2025-03-31 | (m) | (m) | (m) | $7.44M | (m) | (m) | $62.19M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $8.55M | (m) | (m) | $58.53M | (m) |
| 2024-09-30 | (m) | (m) | (m) | $9.66M | (m) | (m) | $58.59M | (m) |
| 2024-06-30 | (m) | (m) | (m) | $10.78M | (m) | (m) | $57.31M | (m) |
| 2024-03-31 | (m) | (m) | (m) | $11.89M | (m) | (m) | $55.49M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $15.51M | (m) | (m) | $55.35M | (m) |
| 2023-09-30 | (m) | (m) | $2.50M | $8.75M | (m) | (m) | $43.97M | (m) |
| 2023-06-30 | (m) | (m) | $2.50M | $9.38M | (m) | (m) | $45.63M | (m) |
| 2023-03-31 | (m) | (m) | $2.50M | $10.00M | (m) | (m) | $41.66M | (m) |
| 2022-12-31 | (m) | (m) | $0.00 | $0.00 | (m) | (m) | $25.71M | (m) |
| 2018-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $5.86M | (m) |
| 2018-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $7.30M | (m) |
| 2018-06-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $6.13M | (m) |
| 2018-03-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $6.03M | (m) |
| 2017-12-31 | (m) | (m) | $414.88K | $0.00 | (m) | (m) | $6.86M | (m) |
| 2017-09-30 | (m) | (m) | $506.89K | $0.00 | (m) | (m) | $14.78M | (m) |
| 2017-06-30 | (m) | (m) | $554.71K | $89.11K | (m) | (m) | $15.13M | (m) |
| 2017-03-31 | (m) | (m) | $549.74K | $229.78K | (m) | (m) | $15.91M | (m) |
| 2016-12-31 | (m) | (m) | $544.83K | $369.18K | (m) | (m) | $15.55M | (m) |
| 2016-09-30 | (m) | (m) | $539.95K | $507.34K | (m) | (m) | $18.24M | (m) |
| 2016-06-30 | (m) | (m) | $535.12K | $644.17K | (m) | (m) | $19.87M | (m) |
| 2016-03-31 | (m) | (m) | $530.33K | $779.72K | (m) | (m) | $17.66M | (m) |
| 2015-12-31 | (m) | (m) | $525.59K | $914.14K | (m) | (m) | $17.56M | (m) |
| 2015-09-30 | (m) | (m) | $520.89K | $1.05M | (m) | (m) | $12.17M | (m) |
| 2015-06-30 | (m) | (m) | $516.23K | $1.18M | (m) | (m) | $10.95M | (m) |
| 2015-03-31 | (m) | (m) | $511.61K | $1.31M | (m) | (m) | $10.15M | (m) |
| 2014-12-31 | (m) | (m) | $507.03K | $1.44M | (m) | (m) | $10.10M | (m) |
| 2014-09-30 | (m) | (m) | $502.50K | $1.57M | (m) | (m) | $11.07M | (m) |
| 2014-06-30 | (m) | (m) | $498.00K | $1.70M | (m) | (m) | $11.53M | (m) |
| 2014-03-31 | (m) | (m) | $493.55K | $1.82M | (m) | (m) | $9.94M | (m) |
| 2013-12-31 | (m) | (m) | $489.13K | $1.95M | (m) | (m) | $9.23M | (m) |
| 2013-09-30 | (m) | (m) | (m) | $2.56M | (m) | (m) | $11.96M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |